title: MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression.
abstract: Asbestos-related lung cancer accounts for 4-12% of lung cancers worldwide. We have previously identified ADAM28 as a putative oncogene involved in asbestos-related lung adenocarcinoma (ARLC-AC). We hypothesised that similarly gene expression profiling of asbestos-related lung squamous cell carcinomas (ARLC-SCC) may identify candidate oncogenes for ARLC-SCC. We undertook a microarray gene expression study in 56 subjects; 26 ARLC-SCC (defined as lung asbestos body (AB) counts >20AB/gram wet weight (gww) and 30 non-asbestos related lung squamous cell carcinoma (NARLC-SCC; no detectable lung asbestos bodies; 0AB/gww). Microarray and bioinformatics analysis identified six candidate genes differentially expressed between ARLC-SCC and NARLC-SCC based on statistical significance (p<0.001) and fold change (FC) of >2-fold. Two genes MS4A1 and CARD18, were technically replicated by qRT-PCR and showed consistent directional changes. As we also found MS4A1 to be overexpressed in ARLC-ACs, we selected this gene for biological validation in independent test sets (one internal, and one external dataset (2 primary tumor sets)). MS4A1 RNA expression dysregulation was validated in the external dataset but not in our internal dataset, likely due to the small sample size in the test set as immunohistochemical (IHC) staining for MS4A1 (CD20) showed that protein expression localized predominantly to stromal lymphocytes rather than tumor cells in ARLC-SCC. We conclude that differential expression of MS4A1 in this comparative gene expression study of ARLC-SCC versus NARLC-SCC is a stromal signal of uncertain significance, and an example of the rationale for tumor cell enrichment in preparation for gene expression studies where the aim is to identify markers of particular tumor phenotypes. Finally, our study failed to identify any strong gene candidates whose expression serves as a marker of asbestos etiology. Future research is required to determine the role of stromal lymphocyte MS4A1 dysregulation in pulmonary SCCs caused by asbestos.
authors.affiliation: School of Medicine, The University of Queensland Thoracic Research Centre, Queensland, Australia. casey.wright@uqconnect.edu.au
authors.forename: Casey M
authors.initials: CM
authors.lastname: Wright
authors.forename: Santiyagu M
authors.initials: SM
authors.lastname: Savarimuthu Francis
authors.forename: Maxine E
authors.initials: ME
authors.lastname: Tan
authors.forename: Maria U
authors.initials: MU
authors.lastname: Martins
authors.forename: Clay
authors.initials: C
authors.lastname: Winterford
authors.forename: Morgan R
authors.initials: MR
authors.lastname: Davidson
authors.forename: Edwina E
authors.initials: EE
authors.lastname: Duhig
authors.forename: Belinda E
authors.initials: BE
authors.lastname: Clarke
authors.forename: Nicholas K
authors.initials: NK
authors.lastname: Hayward
authors.forename: Ian A
authors.initials: IA
authors.lastname: Yang
authors.forename: Rayleen V
authors.initials: RV
authors.lastname: Bowman
authors.forename: Kwun M
authors.initials: KM
authors.lastname: Fong
mesh_terms: D000368:Aged; D018951:Antigens, CD20 / Q000378:metabolism*; D001402:B-Lymphocytes / Q000276:immunology*; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology / Q000378:metabolism*; D019295:Computational Biology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D018951:Antigens, CD20